Transcription-factor-modulating agents: precision and selectivity in drug design (Q34753590)

4 August 2017

1 reference

title

Transcription-factor-modulating agents: precision and selectivity in drug design (English)

1 reference

4 August 2017

Papavassiliou AG

1

1 reference

4 August 2017

1 August 1998

1 reference

Trends in Molecular Medicine

4 August 2017

1 reference

4 August 2017

4

1 reference

4 August 2017

8

1 reference

4 August 2017

358-366

1 reference

The biochemistry of transcription in eukaryotes: a paradigm for multisubunit regulatory complexes

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Compilation of vertebrate-encoded transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Molecular medicine. Transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Multiple steps in the regulation of transcription-factor level and activity

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Transcriptional activation: a complex puzzle with few easy pieces

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Interaction of a peptidomimetic aminimide inhibitor with elastase

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

An approach to computer-aided inhibitor design: application to cathepsin L

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

CLIX: A search algorithm for finding novel ligands capable of binding proteins of known three‐dimensional structure

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Lipophilicity in molecular modeling

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

GenStar: a method for de novo drug design.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Discovery of new anticancer drugs by computer-aided drug design

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

STATs and gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Modular binding domains in signal transduction proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Structure of the NF-kappa B p50 homodimer bound to DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Transcription-modulating drugs: mechanism and selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2898%2901303-3

7 January 2021

10.1016/S1357-4310(98)01303-3

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

9755455